Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR−/− and ApoE−/− mice - Concepedia

Concepedia

Publication | Closed Access

Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR−/− and ApoE−/− mice

44

Citations

26

References

2012

Year

Sung Kee Ryu, Timothy J. King, Kazutoshi Fujioka, Jennifer Pattison, Fredrick J. Pashkow, Sotirios Tsimikas

Atherosclerosis

InflammationLipoprotein LevelsCardiovascular DiseaseApoe−/− MiceMedicineLipid PeroxidationImmunologyVascular BiologyLipoprotein MetabolismOral Astaxanthin ProdrugPharmacologyCardiovascular Disease PathogenesisAtherosclerosisDyslipidemia

References

	Year	Citations

Page 1

Page 1